Jiedu recipe (JR), a traditional Chinese medicinal formula, has demonstrated efficacy in preventing the metastasis of hepatocellular carcinoma (HCC). However, the underlying mechanism remains largely unknown.

Shufeng Jiedu capsules (SFJDC), a patented herbal drug composed of eight medicinal plants, is used for the treatment of different viral respiratory tract infectious diseases.

2024年5月27日 · Previous clinical studies have demonstrated that Shufeng Jiedu (SFJD) capsule, a Chinese herbal patent medicine, effectively alleviates symptoms associated with the common cold, H1N1 influenza, and COVID-19.

Jiedu Recipe (JR), composed of valvate actinidia root, salvia chinensis, pseudobulbus cremastrae seu pleiones, and endothelium corneum gigeriae galli, has been utilized for the treatment of HCC and preventing tumor recurrence in postoperative HCC patients for more than a decade [7].

2023年9月1日 · The registered Chinese herbal medicine Shufeng Jiedu Capsule (SFJD) has been used to treat different epidemics like influenza A virus subtype H1N, and has been shown to improve symptoms such as fever, sore throat, headache, nasal congestion and cough.

2022年7月4日 · Shufeng Jiedu (SFJD) capsule, an oral Chinese patent medicine, was licensed as an over-the-counter drug by the National Medical Products Administration (NMPA) in July 2021 ( NMPA, 2021 ), contains eight medicinal herbs.

Background: Shufeng Jiedu capsules (SFJDC), a patented herbal drug composed of eight medicinal plants, is used for the treatment of different viral respiratory tract infectious diseases.

2023年4月25日 · Shufeng Jiedu Capsule (SFJDC), composed of eight herbs, is a big brand traditional Chinese medicine (TCM) for the treatment of different respiratory tract infectious diseases with good clinical efficacy and few side effects.

2022年10月13日 · Shufeng Jiedu capsule (SFJD) is a commonly used Chinese patent medicine in China. Some studies have reported that SFJD has therapeutic effects in patients diagnosed with COVID-19.

Chronic obstructive pulmonary disease (COPD) represents one of the leading causes of death worldwide. Published clinical trials suggest that the Chinese patent herbal medicine Shufeng Jiedu capsule (SFJD) is safe and may be effective for treating ...

2020年12月11日 · Xia J, Rong L, Sawakami T, et al. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.

2024年8月30日 · Shufeng Jiedu Capsules (SFJD), a traditional Chinese medicine preparation, are widely used in the clinical treatment of influenza, yet their mechanism of action remains unclear.

2022年10月18日 · Depending on the search database, the following search terms (or Chinese database equivalent to Chinese) are used: “traditional Chinese medicine,” “traditional Chinese medicine decoction,” “Chinese patent medicine,” “Chinese medicine injection,” “Chinese medicine,” “integrated Chinese and Western medicine ...

Background: Shufeng Jiedu capsule has been widely used in China for acute upper respiratory tract infections (AURTIs). The aim of this study was to evaluate its effectiveness and safety for AURTIs.

2022年10月18日 · Phytotherapy Research is a medicinal chemistry journal for biochemists, pharmacologists, & toxicologists interested in medicinal plant research & clinical applications.

Find company research, competitor information, contact details & financial data for Guangzhou Panyu District Shibi Jiedu Na Village Economic Development Company of Guangzhou, Guangdong. Get the latest business insights from Dun & Bradstreet.

ShuFeng JieDu capsule (SFJDC), a traditional Chinese medicine, has been recommended for the treatment of COVID-19 infections. However, the pharmacological mechanism of SFJDC still remains vague to date. The active ingredients and their target genes ...

2021年10月11日 · Efficacy observation of Maxing Xuanfei Jiedu decoction on moderate COVID-19 patients

Xia J, Rong L, Sawakami T, et al. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.